Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Dec-18 6:00 PM View:  | Aratana Therapeutics, Inc. (PETX) | 17-Dec-18 | Market Sale (Planned) | 46,094 | $5.85 | $269,788.00 | (7%) 649.72K to 603.62K | 24% |
| 31-Oct-18 6:00 PM View: | Aratana Therapeutics, Inc. (PETX) | 30-Oct-18 | Market Sale (Planned) | 11,513 | $5.86 | $67,453.50 | (2%) 661.23K to 649.72K | 25% |
| 21-Sep-18 6:31 PM View: | Aratana Therapeutics, Inc. (PETX) | 21-Sep-18 | Market Sale (Planned) | 75,000 | $6.06 | $454,305.00 | (10%) 736.23K to 661.23K | 27% |
| 30-Jul-18 5:51 PM View: | Aratana Therapeutics, Inc. (PETX) | 30-Jul-18 | Market Sale (Planned) | 11,513 | $4.33 | $49,842.10 | (2%) 747.74K to 736.23K | (2%) |
| 30-Apr-18 5:49 PM View: | Aratana Therapeutics, Inc. (PETX) | 30-Apr-18 | Market Sale (Planned) | 11,513 | $5.00 | $57,582.30 | 2% 736.23K to 747.74K | (12%) |
| 01-Feb-18 5:29 PM View: | Aratana Therapeutics, Inc. (PETX) | 30-Jan-18 | Market Sale (Planned) | 19,367 | $4.77 | $92,301.20 | (2%) 778.62K to 759.26K | 7% |
| 26-Jan-18 5:32 PM View: | Aratana Therapeutics, Inc. (PETX) | 25-Jan-18 | Grant | 135,600 | -- | -- | 21% 643.02K to 778.62K | |
| 21-Dec-17 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 20-Dec-17 | Option Exercise | 26,667 | $3.14 | $83,734.40 | 4% 616.36K to 643.02K | |
| 13-Nov-17 6:05 PM View: | Aratana Therapeutics, Inc. (PETX) | 10-Nov-17 | Market Sale (Planned) | 50,000 | $7.00 | $350,000.00 | (8%) 666.36K to 616.36K | 37% |
| 04-Oct-17 6:00 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Oct-17 | Market Sale (Planned) | 50,000 | $6.24 | $312,115.00 | (7%) 716.36K to 666.36K | 29% |
| 18-Apr-17 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 17-Apr-17 | Option Exercise | 46,666 | $3.14 | $146,531.00 | 6% 719.69K to 766.36K | |
| 18-Apr-17 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 17-Apr-17 | Market Option Sale (Planned) | 46,666 | $5.54 | $258,670.00 | (6%) 766.36K to 719.69K | 20% |
| 18-Apr-17 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 17-Apr-17 | Market Sale (Planned) | 3,334 | $5.54 | $18,480.40 | (< 1%) 719.69K to 716.36K | 20% |
| 31-Jan-17 6:03 PM View: | Aratana Therapeutics, Inc. (PETX) | 27-Jan-17 | Market Sale (Planned) | 50,000 | $7.72 | $385,875.00 | (6%) 769.69K to 719.69K | 43% |
| 17-Jan-17 6:10 PM View: | Aratana Therapeutics, Inc. (PETX) | 13-Jan-17 | Grant | 139,900 | -- | -- | 22% 629.79K to 769.69K | |
| 05-Jan-17 4:31 PM View: | PharmAthene, Inc. (ALT) | 04-Jan-17 | Option Exercise | 70,000 | $2.59 | $181,500.00 | 52% 135.0K to 205.0K | |
| 16-Dec-16 5:49 PM View: | Aratana Therapeutics, Inc. (PETX) | 15-Dec-16 | Market Sale (Planned) | 50,000 | $7.63 | $381,380.00 | (7%) 679.79K to 629.79K | 45% |
| 16-Dec-16 5:49 PM View: | Aratana Therapeutics, Inc. (PETX) | 14-Dec-16 | Gift | 50,000 | -- | -- | (7%) 729.79K to 679.79K | |
| 20-Sep-16 9:37 PM View: | PharmAthene, Inc. (ALT) | 16-Sep-16 | Option Exercise | 110,004 | $1.60 | $175,907.00 | 440% 25.0K to 135.0K | |
| 10-Aug-16 6:19 PM View: | Aratana Therapeutics, Inc. (PETX) | 09-Aug-16 | Market Sale (Planned) | 50,000 | $9.25 | $462,500.00 | (6%) 779.79K to 729.79K | 55% |
| 17-Jun-16 7:16 PM View: | Aratana Therapeutics, Inc. (PETX) | 17-Jun-16 | Market Sale (Planned) | 25,000 | $6.32 | $158,020.00 | (3%) 804.79K to 779.79K | 35% |
| 17-Jun-16 7:16 PM View: | Aratana Therapeutics, Inc. (PETX) | 16-Jun-16 | Market Sale (Planned) | 75,000 | $6.24 | $468,292.00 | (9%) 879.79K to 804.79K | 34% |
| 26-Jan-16 6:15 PM View: | Aratana Therapeutics, Inc. (PETX) | 22-Jan-16 | Grant | 97,500 | -- | -- | 12% 782.29K to 879.79K | |
| 23-Mar-15 5:28 PM View: | PharmAthene, Inc. (ALT) | 19-Mar-15 | Market Purchase | 25,000 | $1.65 | $41,212.50 | 100% 0 to 25.0K | (135%) |
| 02-Feb-15 6:28 PM View: | Aratana Therapeutics, Inc. (PETX) | 29-Jan-15 | Grant | 85,900 | -- | -- | 12% 696.39K to 782.29K | |
| 13-Jan-15 6:04 PM View: | Aratana Therapeutics, Inc. (PETX) | 13-Jan-15 | Market Sale (Planned) | 75,000 | $19.23 | $1,442,410.00 | (10%) 771.39K to 696.39K | 79% |
| 06-Jan-15 5:05 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Jan-15 | Market Sale (Planned) | 25,000 | $17.87 | $446,648.00 | (3%) 796.39K to 771.39K | 77% |
| 06-Jan-15 5:05 PM View: | Aratana Therapeutics, Inc. (PETX) | 29-Dec-14 | Gift | 25,000 | -- | -- | (3%) 821.39K to 796.39K | |
| 04-Sep-14 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 03-Sep-14 | Option Exercise | 25,000 | $6.00 | $150,000.00 | 3% 796.39K to 821.39K | |
| 04-Sep-14 6:06 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Sep-14 | Market Option Sale (Planned) | 25,000 | $11.67 | $291,862.00 | (3%) 821.39K to 796.39K | 65% |
| 02-Jun-14 6:55 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Jun-14 | Market Sale (Planned) | 25,000 | $13.47 | $336,805.00 | (3%) 846.39K to 821.39K | 69% |
| 05-Mar-14 5:21 PM View: | Aratana Therapeutics, Inc. (PETX) | 03-Mar-14 | Acquisition (other) | 5,203 | -- | -- | < 1% 841.19K to 846.39K | |
| 14-Jan-14 6:41 PM View: | Aratana Therapeutics, Inc. (PETX) | 13-Jan-14 | Grant | 225,000 | -- | -- | 37% 616.19K to 841.19K | |
| 03-Jul-13 6:04 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Jul-13 | Conversion | 11,281 | -- | -- | 2% 596.57K to 607.86K | |
| 03-Jul-13 6:04 PM View: | Aratana Therapeutics, Inc. (PETX) | 02-Jul-13 | Purchase | 8,333 | $6.00 | $49,998.00 | 1% 607.86K to 616.19K | |
| 05-Sep-08 3:46 PM View: | Omrix Biopharmaceuticals, I... (OMRI) | 04-Sep-08 | Grant | 2,000 | -- | -- | 100% 2.0K to 4.0K | |
| 14-Aug-07 2:41 PM View: | Omrix Biopharmaceuticals, I... (OMRI) | 13-Aug-07 | Option Exercise | 2,750 | $12.27 | $33,742.50 | 138% 2.0K to 4.75K | |
| 14-Aug-07 2:41 PM View: | Omrix Biopharmaceuticals, I... (OMRI) | 13-Aug-07 | Market Option Sale | 2,750 | $29.49 | $81,097.50 | (58%) 4.75K to 2.0K | 47% |
| 01-Jun-07 11:16 AM View: | Omrix Biopharmaceuticals, I... (OMRI) | 31-May-07 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K |